true
Cell Biology Research
Pgap3遺伝子のfloxedマウス。エクソン7と8がloxP配列で挟まれている (エクソン8の下流にfrtで挟まれたneoカセットをもつ) 。Pgap3遺伝子はGPIアンカーの脂質リモデリングに関与しており、この脂質リモデリングによりGPIアンカー型蛋白質がラフトに局在できるようになる。全身でPGAP3遺伝子を欠損させると、頻度は低いが生後6ヶ月頃より自己抗体 (anti DNA 抗体) を産出する個体がwildに比べて有意に多い。GPIアンカー型蛋白質がラフトに局在しない。体重がやや小さいが正常に発育し、生殖能力も正常である。In vitro assayにてT細胞機能の亢進がみられている。
Heterozygote x Wild-type [C57BL/6JJcl]
Heterozygote x Wild-type [C57BL/6JJcl]
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.
Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol>
条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。<br>非営利機関が非営利目的の教育・研究用に用いる場合以外は、大阪大学と別途MTAを締結すること。5年経過後も使用を希望するときは改めて寄託者から承諾を得るものとする。
大阪大学微生物病研究所・王冶陶、木下タロウ(2007)。EGRG01 ES細胞を用いて作出。C57BL/6Jへ戻し交配された(N10以上)。
木下 タロウ
FLP/frt system
B6.Cg-Pgap3<tm1>
B6.Cg-Pgap3<tm1>
RBRC06210
Pgap3 floxed, B6-Pgap3 floxed
Pgap3 floxed, B6-Pgap3 floxed
D (more than 6 months)
Developed by Yetao Wang and Taroh Kinoshita, Research Institute for Microbial Diseases, Osaka University in 2007. EGRG01 ES cells derived from (129S2 x C57BL/6CrSlc)F1-Tg(GFP) were used for the generation of floxed mice. The mutant mice were backcrossed to C57BL/6J over 10 times.
D(6か月以上)
Neo耐性遺伝子、PGK promoter、マウスPgap3遺伝子、P1 ファージLoxP sites yeast flippase target sites
Taroh KINOSHITA
Cre/loxP system
EGR-G01 [129S2 x C57BL/6NCr-Tg(CAG/Acr-EGFP)]
Pgap3 gene floxed mice. Exon 7 and 8 were flanked by loxP sites. A FRT flanked neo cassette was inserted after the exon 8.